Related Experiment Video
Updated: Jun 29, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Phosphoglycerate Kinase 1: An Effective Therapeutic Target in Cancer
Ailin Qiu1, Xiaosha Wen2, Qingshuang Zou3
1Institute of Pharmacy and Pharmacology, School of Pharmaceutical Science, Hengyang Medical School, University of South China, 421001 Hengyang, Hunan, China.
Abstract:
Phosphoglycerate kinase 1 (PGK1) serves as a pivotal enzyme in the cellular glycolysis pathway, facilitating adenosine-triphosphate (ATP) production in tumor cells and driving the Warburg effect. PGK1 generates ATP through the reversible phosphorylation reaction of 1,3-bisphosphoglycerate (1,3-BPG) to Mg-adenosine-5'-diphosphate (Mg-ADP). In addition to its role in regulating cellular metabolism, PGK1 plays a pivotal role in autophagy induction, regulation of the tricarboxylic acid cycle (TCA), and various mechanisms including tumor cell drug resistance, and so on. Given its multifaceted functions within cells, the involvement of PGK1 in many types of cancer, including breast cancer, astrocytoma, metastatic colon cancer, and pancreatic ductal adenocarcinoma, is intricate. Notably, PGK1 can function as an intracellular protein kinase to coordinate tumor growth, migration, and invasion via posttranslational modifications (PTMs). Furthermore, elevated expression levels of PGK1 have been observed in cancer tissues, indicating its association with unfavorable treatment outcomes and prognosis. This review provides a comprehensive summary of PGK1's expression pattern, structural features, functional properties, involvement in PTMs, and interaction with tumors. Additionally highlighted are the prospects for developing and applying related inhibitors that confirm the indispensable value of PGK1 in tumor progression.
Insights
Phosphoglycerate kinase 1 (PGK1) is crucial for tumor cell energy production and cancer progression. Inhibiting PGK1 shows promise for developing new cancer therapies by targeting its multifaceted roles in tumor growth and drug resistance.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Phosphoglycerate kinase 1 (PGK1) is a key enzyme in glycolysis, essential for adenosine-triphosphate (ATP) production in cancer cells.
- PGK1 contributes to the Warburg effect, a hallmark of cancer metabolism.
- Beyond glycolysis, PGK1 influences autophagy, the tricarboxylic acid cycle (TCA), and tumor drug resistance.
Purpose of the Study:
- To comprehensively review the expression, structure, and functions of PGK1 in cancer.
- To elucidate PGK1's role in tumor growth, migration, invasion, and posttranslational modifications (PTMs).
- To highlight the therapeutic potential of PGK1 inhibitors in cancer treatment.
Main Methods:
- Literature review of studies on PGK1 in various cancers.
- Analysis of PGK1 expression patterns and correlation with patient prognosis.
- Examination of PGK1's involvement in cellular signaling pathways and PTMs.
Main Results:
- Elevated PGK1 expression is linked to poor prognosis in multiple cancer types, including breast, colon, and pancreatic cancers.
- PGK1 acts as an intracellular protein kinase, coordinating tumor progression through PTMs.
- PGK1's diverse roles underscore its significance in oncogenesis.
Conclusions:
- PGK1 is a critical factor in tumor progression and a potential therapeutic target.
- Understanding PGK1's functions and interactions is vital for developing novel anti-cancer strategies.
- Targeting PGK1 offers a promising avenue for improving cancer treatment outcomes.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Amplifying Signals via Enzymatic Cascade
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

